UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.19 +0.81 (+1.03%) GOLD FUTURES
2,316.60 -7.60 (-0.33%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,282.84 -1,131.91 (-2.25%)
Travere Therapeutics, Inc. (TVTX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 514.63M |
| Enterprise value | 477.60M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.32 |
| Price/book (mrq) | 6.95 |
| Enterprise value/revenue | 3.07 |
| Enterprise value/EBITDA | -1.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -58.54% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 19.54 |
| 52-week low 3 | 5.12 |
| 50-day moving average 3 | 7.02 |
| 200-day moving average 3 | 9.07 |
Share statistics
| Avg vol (3-month) 3 | 1.27M |
| Avg vol (10-day) 3 | 1.56M |
| Shares outstanding 5 | 76.13M |
| Implied shares outstanding 6 | 76.13M |
| Float 8 | 56.16M |
| % held by insiders 1 | 0.65% |
| % held by institutions 1 | 117.46% |
| Shares short (15 Apr 2024) 4 | 11.8M |
| Short ratio (15 Apr 2024) 4 | 9.43 |
| Short % of float (15 Apr 2024) 4 | 17.45% |
| Short % of shares outstanding (15 Apr 2024) 4 | 15.51% |
| Shares short (prior month 15 Mar 2024) 4 | 10.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -103.47% |
| Operating margin (ttm) | -335.91% |
Management effectiveness
| Return on assets (ttm) | -35.53% |
| Return on equity (ttm) | -315.89% |
Income statement
| Revenue (ttm) | 155.72M |
| Revenue per share (ttm) | 2.04 |
| Quarterly revenue growth (yoy) | 33.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -376.56M |
| Net income avi to common (ttm) | -415.73M |
| Diluted EPS (ttm) | -5.41 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 441.04M |
| Total cash per share (mrq) | 5.79 |
| Total debt (mrq) | 404.02M |
| Total debt/equity (mrq) | 545.44% |
| Current ratio (mrq) | 2.78 |
| Book value per share (mrq) | 0.97 |
Cash flow statement
| Operating cash flow (ttm) | -317.91M |
| Levered free cash flow (ttm) | -159.79M |
© 2024 Yahoo. All rights reserved.